Recent Trends in Ménière’s Disease Management in India: Results from the DIRECTION Cross-sectional Online Survey

Simple item page
dc.contributor.authorAgrawal, Pen_US
dc.contributor.authorJain, Men_US
dc.contributor.authorSharma, Aen_US
dc.contributor.authorRana, VJen_US
dc.date.accessioned2025-08-13T11:28:22Z
dc.date.available2025-08-13T11:28:22Z
dc.date.issued2025-06
dc.description.abstractBackground: Ménière’s disease (MD) is an inner ear ailment that can be effectively controlled with appropriate treatment and disease management. Objectives: The DIRECTION (Differential dIagnosis for compREhension of Causes, Triggers, and Indications Of MéNière’s disease) study was designed to highlight the major causes, symptoms, treatments, and disease management of MD from the perspective of clinical physicians and healthcare practitioners (HCPs) across India. Materials and Methods: A national, cross-sectional survey was conducted to record the responses of HCPs regarding MD symptoms, patient complaints, diagnosis, and dosing regimen of preferred medication. The survey responses were recorded from consulting physicians with specialties in ear, nose, and throat, chest, and neurology across the northern, southern, eastern, and western regions of India. Results: According to 89% of the HCPs who participated in this nationwide survey, 10%–40% of the patients visited them with dizziness and vertigo as primary symptoms for MD. Nearly 64% of the physicians diagnosed patients based on their symptom history, generally when the disease has progressed to its middle stage. The majority of the clinicians prefer 16 mg betahistine at twice-a-day frequency. Most of the respondents agreed that there was no significant impact of COVID-19 infection on initiation and progression of MD. Conclusion: Vertigo and dizziness are the most common symptoms of MD, and the disease is generally detected during its middle stage. Patient counseling and education, being one of the most important aspects in disease management, must be promoted.en_US
dc.identifier.affiliationsAssistant General Manager, Medical Affairs, Mankind Pharmaceuticals Pvt. Ltd., New Delhi, Indiaen_US
dc.identifier.affiliationsDeputy Marketing Manager, Mankind Pharmaceuticals Pvt. Ltd., New Delhi, Indiaen_US
dc.identifier.affiliationsSenior Product Executive, Mankind Pharmaceuticals Pvt. Ltd., New Delhi, Indiaen_US
dc.identifier.affiliationsMedical Affairs, Neovation Consultancy Services, Singaporeen_US
dc.identifier.citationAgrawal P, Jain M, Sharma A, Rana VJ. Recent Trends in Ménière’s Disease Management in India: Results from the DIRECTION Cross-sectional Online Survey. Indian Journal of Public Health. 2025 Jun; 69(2): 191-196en_US
dc.identifier.issn0019-557X
dc.identifier.issn2229-7693
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/253910
dc.languageenen_US
dc.publisherWolters Kluwer – Medknowen_US
dc.relation.issuenumber2en_US
dc.relation.volume69en_US
dc.source.urihttps://doi.org/10.4103/ijph.ijph_387_24en_US
dc.subjectBetahistineen_US
dc.subjectdizzinessen_US
dc.subjecthearing lossen_US
dc.subjectMénière’s diseaseen_US
dc.subjectsurvey?based studyen_US
dc.subjectvertigoen_US
dc.titleRecent Trends in Ménière’s Disease Management in India: Results from the DIRECTION Cross-sectional Online Surveyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
IJPH2025v69n2p191.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Public Health